Search results for “Alpha virus” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 74 patents, we discovered top 27 key players by total patent application. Omnicyte Ltd., Janssen Vaccines & Prevention BV, AlphaVax, Inc. are dominant in this area. They take 36.49% of the total patent filing.
Omnicyte Ltd.
United Kingdom
Patent: 12
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 8
AlphaVax, Inc.
North Carolina, United States
Patent: 7
Novartis Vaccines & Diagnostics, Inc.
New Jersey, United States
Patent: 6
Pharmaq AS
Oslo, Norway
Patent: 4
Immorna (Hangzhou) Biotechnology Co., Ltd.
China
Patent: 4
Intervet International BV
Noord-Brabant, Netherlands
Patent: 3
Guangzhou Virotech Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 3
Connaught Laboratories Ltd.
Ontario, Canada
Patent: 3
EMD Millipore Corp.
Massachusetts, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 19 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Immorna (Hangzhou) Biotechnology Co., Ltd., Omnicyte Ltd., EMD Millipore Corp. take 47.37% of patent filing during this period.
Immorna (Hangzhou) Biotechnology Co., Ltd.
China
Patent: 4
Omnicyte Ltd.
United Kingdom
Patent: 3
EMD Millipore Corp.
Massachusetts, United States
Patent: 2
Principal Capital Group, Inc. (Old)
California, United States
Patent: 2
Takeda Vaccines, Inc.
Montana, United States
Patent: 2
Intervet International BV
Noord-Brabant, Netherlands
Patent: 2
Chengdu Xinnuomin Biotechnology Co., Ltd.
Sichuan Sheng, China
Patent: 2
The Board of Regents of The University of Texas System
Texas, United States
Patent: 1
National Technology & Engineering Solutions of Sandia LLC
New Mexico, United States
Patent: 1
TechnoVax, Inc.
New York, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 19 patents in last 5 years, we discover 7 new entrants. Immorna (Hangzhou) Biotechnology Co., Ltd., EMD Millipore Corp., Principal Capital Group, Inc. (Old) are the most active new entrants in this area.
Immorna (Hangzhou) Biotechnology Co., Ltd.
China
Patent: 4
EMD Millipore Corp.
Massachusetts, United States
Patent: 2
Principal Capital Group, Inc. (Old)
California, United States
Patent: 2
Takeda Vaccines, Inc.
Montana, United States
Patent: 2
Chengdu Xinnuomin Biotechnology Co., Ltd.
Sichuan Sheng, China
Patent: 2
National Technology & Engineering Solutions of Sandia LLC
New Mexico, United States
Patent: 1
TechnoVax, Inc.
New York, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 15 patents, we discovered top 6 universities and scientific research institutions by total patent application. Washington University in St. Louis, The University of North Carolina at Chapel Hill, Université François-Rabelais de Tours are dominant in this area. They take 40.00% of the total patent filing.
Washington University in St. Louis
Missouri, United States
Patent: 2
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 2
Université François-Rabelais de Tours
France
Patent: 2
University of Washington
Washington, United States
Patent: 1
New York University
New York, United States
Patent: 1
Southwest University
Chongqing Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: